11.11.2009 • News

Arch Chemicals Q2 Profit Slips

Arch Chemicals said that second-quarter profit fell as lower volumes and unfavourable foreign exchange rates offset higher pricing and the favorable impact of the Advantis acquisition. Net earnings declined to $30.9 million, or $1.23 per share, from $33.2 million, or $1.33 per share, a year earlier, the Norwalk, Connecticut-based company said. Revenue fell to $414.2 million from $469.6 million.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read